Apogee Therapeutics, Inc. Common Stock (APGE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for APGE. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 279 institutions reported holding APGE, with 67.5 million shares worth $8.9 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| VR Adviser | 8,493,321 | $1.1B | UNCHANGED |
| BlackRock | 5,507,032 | $731M | INCREASED |
| Vanguard | 4,557,935 | $605M | INCREASED |
| Hbk Investments L P | 2,850,000 | $378M | NEW |
| FMR | 2,493,137 | $331M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Mark C. Mckenna (Director) | SELL | 7,657 | $651K | 2026-09-03 |
| Mark C. Mckenna (Director) | SELL | 14,461 | $602K | 2026-09-03 |
| Mark C. Mckenna (Director) | SELL | 10,370 | $455K | 2026-09-03 |
| Mark C. Mckenna (Director) | SELL | 150,000 | $4M | 2026-09-03 |
| Mark C. Mckenna (Director) | SELL | 20,000 | 2026-09-03 |
Full institutional holdings, insider history, and congressional trades for Apogee Therapeutics, Inc. Common Stock on SentiSense.